Congressional Efforts to Combat New Street Drug Threat Earn Bipartisan AG Support

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • A bipartisan coalition of 39 AGs sent a letter to Congressional leaders urging the swift passage of the Combatting Illicit Xylazine Act, which would provide resources to fight the recent uptick in overdoses and deaths caused by use of the street drug.
  • Xylazine is manufactured for use as a non-opioid veterinary tranquilizer for large animals, and thus is currently readily available for purchase over Internet sites. The AGs’ letter cites a recent DEA warning that the drug, also known as “tranq” or “zombie drug” when sold on the street, is a deadlier threat to public safety than fentanyl. The AGs warn that the number of fatalities from overdose deaths involving xylazine is rising exponentially.
  • The AGs ask the Congressional leaders to pass the Act, which would classify xylazine as a Schedule III drug and allow the DEA to track the manufacturing and sales of the drug to ensure it is not diverted, among other measures to combat xylazine’s threat to public safety.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide